Page last updated: 2024-08-23

pirfenidone and Recrudescence

pirfenidone has been researched along with Recrudescence in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Ichimura, Y; Ikari, J; Matsumura, A; Matsumura, T; Suzuki, K; Tatsumi, K; Terada, J; Tsushima, K; Yamagishi, K	1
Caruana, DM; Wylie, G	1
Giri, SN; Margolin, SB; Walker, JE	1
Margolin, SB; Walker, JE	1

Trials

2 trial(s) available for pirfenidone and Recrudescence

Article	Year
A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:2 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neurologic Examination; Patient Dropouts; Pyridones; Recurrence; Severity of Illness Index; Treatment Outcome; Urination Disorders	2005
Pirfenidone for chronic progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2001, Volume: 7, Issue:5 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Disability Evaluation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Skills; Multiple Sclerosis, Chronic Progressive; Patient Dropouts; Pilot Projects; Pyridones; Recurrence; Walking	2001

Article

Year

A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England), 2005, Volume: 11, Issue:2

Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Neurologic Examination; Patient Dropouts; Pyridones; Recurrence; Severity of Illness Index; Treatment Outcome; Urination Disorders

2005

Pirfenidone for chronic progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England), 2001, Volume: 7, Issue:5

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Disability Evaluation; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Motor Skills; Multiple Sclerosis, Chronic Progressive; Patient Dropouts; Pilot Projects; Pyridones; Recurrence; Walking

2001

Other Studies

2 other study(ies) available for pirfenidone and Recrudescence

Article	Year
The effects of pirfenidone in patients with an acute exacerbation of interstitial pneumonia. The clinical respiratory journal, 2018, Volume: 12, Issue:4 Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Japan; Male; Prognosis; Pyridones; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor-alpha	2018
Cutaneous reactions to pirfenidone: a new kid on the block. The British journal of dermatology, 2016, Volume: 175, Issue:2 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Facial Dermatoses; Hand Dermatoses; Humans; Male; Pulmonary Fibrosis; Pyridones; Recurrence	2016

Article

Year

The effects of pirfenidone in patients with an acute exacerbation of interstitial pneumonia.

The clinical respiratory journal, 2018, Volume: 12, Issue:4

Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis; Japan; Male; Prognosis; Pyridones; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Necrosis Factor-alpha

2018

Cutaneous reactions to pirfenidone: a new kid on the block.

The British journal of dermatology, 2016, Volume: 175, Issue:2

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Facial Dermatoses; Hand Dermatoses; Humans; Male; Pulmonary Fibrosis; Pyridones; Recurrence

2016